1993
DOI: 10.1007/bf01975708
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological investigations with different protein kinase C inhibitors on IgE-dependent and IgE-independent activation of human basophils

Abstract: In the present study different selective inhibitors of the multifunctional serine/threonine kinase protein kinase C (PKC) were investigated on classical activation pathways of basophils in comparison to the nonselective protein kinase inhibitor staurosporine. The potent inhibitors Ro 31-7549, Ro 31-8220, calphostin C and ilmofosine (BM 41.440), which show selectivity for PKC in vitro, significantly potentiated Fc epsilon RI-mediated histamine release up to 50% vs. controls at concentrations > 10(-7) mumol/l bu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
1

Year Published

1994
1994
2005
2005

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 21 publications
0
2
1
Order By: Relevance
“…The PKC inhibitors Ro 31-7549, Ro 31-8220, and calphostin C induced a dose-dependent inhibition of IgE-mediated histamine release from isolated human skin mast cells (manuscript in preparation). These results are in contrast to those from investigations with basophils showing a dosedependent non-cytotoxic potentiation of IgE-mediated histamine release reflecting the biochemical heterogeneity between both cell types [70,71]. Further evidence for a differential role of PKC (isozymes) comes from experiments with the phorbol ester TPA, a strong ligand and activator ofPKC.…”
Section: Protein Kinase Inhibitorscontrasting
confidence: 72%
“…The PKC inhibitors Ro 31-7549, Ro 31-8220, and calphostin C induced a dose-dependent inhibition of IgE-mediated histamine release from isolated human skin mast cells (manuscript in preparation). These results are in contrast to those from investigations with basophils showing a dosedependent non-cytotoxic potentiation of IgE-mediated histamine release reflecting the biochemical heterogeneity between both cell types [70,71]. Further evidence for a differential role of PKC (isozymes) comes from experiments with the phorbol ester TPA, a strong ligand and activator ofPKC.…”
Section: Protein Kinase Inhibitorscontrasting
confidence: 72%
“…Peripheral basophils were isolated after venipuncture from healthy donors by dextran sedimentation as previously described [9,17], In some experiments buffy coats resulting from dextran sedimentation (4 ml) were layered on top of 3 ml Ficoll-Paque (Pharmacia, Uppsala, Sweden) in 12-ml conical plastic tubes (Sarstedt) and centrifuged at 300 g for 25 min (room temperature). The lymphocyte/monocyte/basophil fraction at the interface was diluted with buffer A to 10 ml and was incubated for 10 min (room temperature, turntable) with 200 pi of CD2+, CD9+ and CD 19+ immunomagnetic beads (Dynal, Hamburg, Germany) to reduce T cells, mono cytes, macrophages, and B cells by a magnetic particle concentrator (Dynal).…”
Section: Introductionmentioning
confidence: 99%
“…The cellular and the supernatant fractions were stored at -2 0°C until determination. Histamine release was de termined in both supernatants and cell pellets using a fluorometric autoanalyzer [9,17]. Histamine release was expressed as a percentage of the total histamine initially in the cells, corrected for the spontaneous release occurring in the absence of secretagogue.…”
Section: Introductionmentioning
confidence: 99%